Benoît De Renzis

881 total citations
15 papers, 138 citations indexed

About

Benoît De Renzis is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, Benoît De Renzis has authored 15 papers receiving a total of 138 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 13 papers in Hematology and 3 papers in Rheumatology. Recurrent topics in Benoît De Renzis's work include Acute Myeloid Leukemia Research (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers) and Multiple Myeloma Research and Treatments (4 papers). Benoît De Renzis is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers) and Multiple Myeloma Research and Treatments (4 papers). Benoît De Renzis collaborates with scholars based in France and Belgium. Benoît De Renzis's co-authors include Pierre Fenaux, Lionel Adès, Bruno Quesnel, Sylvain Thépot, Caroline Dartigeas, Norbert Vey, Cécile Bally, François Dreyfus, Jehane Fadlallah and Pascal Turlure and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Neurology.

In The Last Decade

Benoît De Renzis

12 papers receiving 137 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benoît De Renzis France 5 117 89 67 29 14 15 138
M. F. McMullin United Kingdom 7 147 1.3× 120 1.3× 105 1.6× 45 1.6× 22 1.6× 17 198
Bohrane Slama France 6 154 1.3× 104 1.2× 39 0.6× 8 0.3× 14 1.0× 9 166
Emilio Usala Italy 5 59 0.5× 82 0.9× 47 0.7× 26 0.9× 5 0.4× 6 104
Allison Pike United States 6 82 0.7× 57 0.6× 52 0.8× 18 0.6× 11 0.8× 9 93
Barbara Grohmann-Izay Austria 6 52 0.4× 82 0.9× 37 0.6× 57 2.0× 15 1.1× 11 116
Craig A. Kovitz United States 4 87 0.7× 74 0.8× 20 0.3× 44 1.5× 7 0.5× 13 131
S. Schnittger Germany 6 118 1.0× 42 0.5× 97 1.4× 11 0.4× 30 2.1× 13 156
Ghayas C. Issa United States 6 132 1.1× 28 0.3× 92 1.4× 10 0.3× 31 2.2× 27 156
Claudia Haferlach Germany 5 130 1.1× 45 0.5× 108 1.6× 6 0.2× 46 3.3× 10 160
Fausto Palmieri Italy 2 41 0.4× 57 0.6× 42 0.6× 20 0.7× 6 0.4× 5 75

Countries citing papers authored by Benoît De Renzis

Since Specialization
Citations

This map shows the geographic impact of Benoît De Renzis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoît De Renzis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoît De Renzis more than expected).

Fields of papers citing papers by Benoît De Renzis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benoît De Renzis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoît De Renzis. The network helps show where Benoît De Renzis may publish in the future.

Co-authorship network of co-authors of Benoît De Renzis

This figure shows the co-authorship network connecting the top 25 collaborators of Benoît De Renzis. A scholar is included among the top collaborators of Benoît De Renzis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benoît De Renzis. Benoît De Renzis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bouillon‐Minois, Jean‐Baptiste, et al.. (2025). Contribution of molecular characterization to the diagnosis of MPN in patients with low JAK2V617F variant allelic fraction in a real-world cohort. Annals of Hematology. 104(3). 1587–1596.
2.
Houillier, Caroline, Rénata Ursu, Carole Soussain, et al.. (2024). Unveiling the Clinical and Imaging Signatures of Intravascular Lymphoma of the Central Nervous System: A Multicentric Cohort Study. Annals of Neurology. 97(3). 435–448. 2 indexed citations
3.
Renzis, Benoît De, Maria Fiore, Laurence Sanhès, et al.. (2020). Hémorragie intracérébrale fatale chez un patient atteint d'une leucémie chronique à polynucléaires neutrophiles : à propos d'un cas et revue de la littérature. La Revue de Médecine Interne. 41(8). 552–558. 2 indexed citations
4.
5.
Sébert, Marie, Aspasia Stamatoullas, Thorsten Braun, et al.. (2015). Azacitidine (AZA) Combined with Idarubicin in Higher Risk MDS - Results of a Phase I/II Study By the Groupe Francophone Des Myelodysplasies (GFM). Blood. 126(23). 2884–2884. 2 indexed citations
6.
7.
Renzis, Benoît De, Véronique Mansat‐De Mas, Eric Wattel, et al.. (2013). Prognostic impact of JAK2V617F mutation in myelodysplatic syndromes: A matched case control study. Leukemia Research Reports. 2(2). 64–66. 7 indexed citations
8.
9.
Ianotto, Jean‐Christophe, Emmanuel Gyan, Kamel Laribi, et al.. (2013). Efficacy and safety of pegylated‐interferon α‐2a in myelofibrosis: a study by the FIM and GEM French cooperative groups. British Journal of Haematology. 162(6). 783–791. 57 indexed citations
10.
Toma, Andréa, Sylvie Chevret, Olivier Kosmider, et al.. (2013). A randomized study of lenalidomide (LEN) with or without EPO in RBC transfusion dependent (TD) IPSS low and int-1 (lower risk) myelodysplastic syndromes (MDS) without del 5q resistant to EPO.. Journal of Clinical Oncology. 31(15_suppl). 7002–7002. 10 indexed citations
11.
12.
13.
Bally, Cécile, Raphaël Itzykson, Virginie Siguret, et al.. (2011). Azacitidine (AZA) After Failure of Lenalidomide (LEN) in Low/Int-1 Risk MDS with Del 5q. Blood. 118(21). 2786–2786. 3 indexed citations
14.
Fadlallah, Jehane, Cécile Bally, Bruno Quesnel, et al.. (2010). AZA In the Treatment of Therapy Related MDS and AML (tMDS/AML): a Report on 60 Patients by the Groupe Francophone Des Syndromes Myelodysplasiques (GFM). Blood. 116(21). 2911–2911. 2 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. F. McMullin Breakdown of academic impact, for papers by Bohrane Slama Breakdown of academic impact, for papers by Emilio Usala Breakdown of academic impact, for papers by Allison Pike Breakdown of academic impact, for papers by Barbara Grohmann-Izay Breakdown of academic impact, for papers by Craig A. Kovitz Breakdown of academic impact, for papers by S. Schnittger Breakdown of academic impact, for papers by Ghayas C. Issa Breakdown of academic impact, for papers by Claudia Haferlach Breakdown of academic impact, for papers by Fausto Palmieri
Rankless by CCL
2026